AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Non-Current Assets (2020 - 2026)

Updated

AbCellera Biologics (ABCL) recorded Non-Current Assets of $628.35 million in Q2 2026, down 4.8% from $659.92 million a year earlier and down 2.2% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, AbCellera Biologics reported Non-Current Assets of $628.72 million, up 3.2% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $609.18 million in FY2024 (-1.1%), $616.11 million in FY2023 (+19.5%), $515.42 million in FY2022 (+32.6%) and $388.77 million in FY2021 (+102.3%).
  • The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2025.
  • On a year-over-year basis, Non-Current Assets rose in five of the last eight quarters, with growth averaging 1.5%.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 102.3% in Q4 2021, against a decline of 10.8% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $642.52 million (Q1 2026), $628.72 million (Q4 2025) and $660.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 141.29 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 101.45 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 87.87 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 14.88 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 628.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 628.35 Mn
Mar 31, 2026 642.52 Mn
Dec 31, 2025 628.72 Mn
Sep 30, 2025 660.85 Mn
Jun 30, 2025 659.92 Mn
Mar 31, 2025 579.23 Mn
Dec 31, 2024 609.18 Mn
Sep 30, 2024 649.95 Mn
Jun 30, 2024 640.93 Mn
Mar 31, 2024 649.15 Mn
Dec 31, 2023 616.11 Mn
Sep 30, 2023 592.67 Mn
Jun 30, 2023 606.43 Mn
Mar 31, 2023 557.27 Mn
Dec 31, 2022 515.42 Mn
Sep 30, 2022 506.74 Mn
Jun 30, 2022 449.83 Mn
Mar 31, 2022 417.91 Mn
Dec 31, 2021 388.77 Mn
Sep 30, 2021 368.99 Mn
API Access

AbCellera Biologics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABCL&period=max&api_key=YOUR_API_KEY